TAFAZZIN and Barth syndrome: Demonstrating the ability of our AAV-TAZ vector to restore mtDNA copy numbers in both BTHS patient-derived fibroblast lines further validates AAV-mediated delivery of TAZ as a relevant therapy for BTHS.